<DOC>
	<DOCNO>NCT00055848</DOCNO>
	<brief_summary>RATIONALE : Genetic study may help understand genetic process involve development type cancer . PURPOSE : Clinical trial study cancer-related gene patient colon cancer adenomatous polyp .</brief_summary>
	<brief_title>Genetic Study Familial Factors Patients With Colon Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Identify human colon neoplasia susceptibility gene patient colon cancer adenomatous polyp . - Correlate inheritance novel susceptibility alleles adenomatous polyposis colon colon neoplasia patient . - Correlate colon neoplasia susceptibility presence COX-2 , sPLA2 , DNMT gene patient . - Identify novel gene governs increase susceptibility colon adenoma cancer genome patient .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis colon cancer polyp age 70 Has living full sibling diagnosis colon cancer polyp age 70 No history familial adenomatous polyposis syndrome No hereditary nonpolyposis colon cancer , accord Amsterdam criterion No known I1370K adenomatous polyposis colon susceptibility variant Enrolled 1 follow clinical trial : CLB9581 CLB89803 CLB80001 NOTE : Patients need receive protocol therapy . Patients outside treatment protocol 's followup range eligible . Patients discontinue therapy reason , include toxic effect , eligible . PATIENT CHARACTERISTICS : Age 70 diagnosis Other No significant psychiatric illness would preclude give informed consent No inflammatory bowel disease ( patient sibling )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
</DOC>